Pinilla L, Trejos S, Villarreal O, Aguilera A, Benavides M, Ceballos A, Chacón J, Gómez Y, Escobar M, González M, Iturralde C, Jaramillo J, Jiménez R, Laguna, A, Lee H, Lobán A, Rodríguez Y, Samaniego R, Tablas E

Language: Spanish
References: 6
Page: 312-315
PDF size: 197.38 Kb.

ABSTRACT

The response to viral infection produces a prothrombotic state of hypercoagulability , united with an inflammation of endothelial cells, It can generate platelet dysfunction and predisposition to the formation of thrombus, that, although, are more frequently venous, Also, it can appear in the arterial system and cause heart attacks at any level; thromboembolism and pulmonary hypertension, as well. These manifestations have been captured hospitably and with the egress of patients detected by SARS-CoV-2. The diagnostic criteria of RITAC (abbreviation in Spanish of Thrombotic Immune Response Associated to COVID-19), help to select the patient who is predisposed to this condition; adding that the patient already has a diagnosis of SARS-CoV-2 infection.

REFERENCES

1. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395 (10229): 1033-1034.

2. COVID-19.Una enfermedad multisistémica. Manifestaciones extrapulmonares de COVID-19.La fisiopatología y el impacto clínico de COVID-19 en varios sistemas de órganos. 2020.

3. Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020 [En line 28 Mar 2020]: ehaa231. Available in https://doi.org/10.1093/eurheartj/ehaa231.

4. Gauna ME, Bernava JL. Recomendaciones diagnósticas y terapéuticas ante la respuesta inmune trombótica asociada a COVID-19 (RITAC). CorSalud. 2020; 12 (1): 60-63.

5. Páramo FJ. Coagulación, dímero D y COVID-19: una reflexión de José A Páramo Hernández, presidente de la Sociedad Española de Trombosis y Hemostasia (SETH) [Internet]. Madrid: Sociedad Española de Trombosis y Hemostasia [Citado 22 Mar 2020]. Disponible en: https://www.seth.es/index.php/noticias/noticias/noticias-de-la-seth/1588-coagulacion-dimero-d-y-covid-19.html.

6. Ministerio de Salud Argentina. Recomendaciones condicionales para el abordaje terapéutico de COVID-19 [Internet]. Buenos Aires: Ministerio de Salud Argentina; 2020 [citado 22 Mar 2020]. Disponible en: https://www.argentina.gob.ar/salud/coronavirus-COVID-19/abordaje-terapeutico.